{"title":"Efficacy Analysis of Ear Molding Correction for Congenital Auricular Deformities at Different Ages.","authors":"Lu Liu, Min Liu, You Xu, Lang Xu","doi":"10.1007/s00266-025-05271-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To compare the clinical outcomes of ear molding correction in children with congenital auricular deformities at different ages, explore the optimal timing and latest time window for ear molding correction.</p><p><strong>Methods: </strong>This retrospective study analyzed data from children with congenital auricular deformities who underwent ear molding correction in our department from January 2021 to June 2024. Children were divided into four groups based on their ages at initial treatment: Group A (≤21 days) , Group B (22-42 days) , Group C (43-90 days) , and Group D (≥91 days) . The success rate, treatment duration, and incidence of complications were compared among the four groups.</p><p><strong>Results: </strong>The success rates in Groups A, B, and C were comparable and significantly higher than in Group D (p < 0.05). Notably, the success rate for correcting cryptotia was 100% across all groups. Treatment duration was shortest in Group A (p < 0.05), while there were no statistically significant differences in complication rates among the four groups (p > 0.05).</p><p><strong>Conclusion: </strong>The optimal timing for ear molding correction in children with congenital auricular deformities is within 21 days after birth, ensuring the highest efficiency and shortest treatment duration. If this optimal period is missed, correction within 90 days remains a viable option. Children with cryptotia older than 90 days still respond well to corrective treatment, but the latest age for treatment has not yet been determined.</p><p><strong>Level of evidence iv: </strong>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.</p>","PeriodicalId":7609,"journal":{"name":"Aesthetic Plastic Surgery","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aesthetic Plastic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00266-025-05271-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To compare the clinical outcomes of ear molding correction in children with congenital auricular deformities at different ages, explore the optimal timing and latest time window for ear molding correction.
Methods: This retrospective study analyzed data from children with congenital auricular deformities who underwent ear molding correction in our department from January 2021 to June 2024. Children were divided into four groups based on their ages at initial treatment: Group A (≤21 days) , Group B (22-42 days) , Group C (43-90 days) , and Group D (≥91 days) . The success rate, treatment duration, and incidence of complications were compared among the four groups.
Results: The success rates in Groups A, B, and C were comparable and significantly higher than in Group D (p < 0.05). Notably, the success rate for correcting cryptotia was 100% across all groups. Treatment duration was shortest in Group A (p < 0.05), while there were no statistically significant differences in complication rates among the four groups (p > 0.05).
Conclusion: The optimal timing for ear molding correction in children with congenital auricular deformities is within 21 days after birth, ensuring the highest efficiency and shortest treatment duration. If this optimal period is missed, correction within 90 days remains a viable option. Children with cryptotia older than 90 days still respond well to corrective treatment, but the latest age for treatment has not yet been determined.
Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
期刊介绍:
Aesthetic Plastic Surgery is a publication of the International Society of Aesthetic Plastic Surgery and the official journal of the European Association of Societies of Aesthetic Plastic Surgery (EASAPS), Società Italiana di Chirurgia Plastica Ricostruttiva ed Estetica (SICPRE), Vereinigung der Deutschen Aesthetisch Plastischen Chirurgen (VDAPC), the Romanian Aesthetic Surgery Society (RASS), Asociación Española de Cirugía Estética Plástica (AECEP), La Sociedad Argentina de Cirugía Plástica, Estética y Reparadora (SACPER), the Rhinoplasty Society of Europe (RSE), the Iranian Society of Plastic and Aesthetic Surgeons (ISPAS), the Singapore Association of Plastic Surgeons (SAPS), the Australasian Society of Aesthetic Plastic Surgeons (ASAPS), the Egyptian Society of Plastic and Reconstructive Surgeons (ESPRS), and the Sociedad Chilena de Cirugía Plástica, Reconstructiva y Estética (SCCP).
Aesthetic Plastic Surgery provides a forum for original articles advancing the art of aesthetic plastic surgery. Many describe surgical craftsmanship; others deal with complications in surgical procedures and methods by which to treat or avoid them. Coverage includes "second thoughts" on established techniques, which might be abandoned, modified, or improved. Also included are case histories; improvements in surgical instruments, pharmaceuticals, and operating room equipment; and discussions of problems such as the role of psychosocial factors in the doctor-patient and the patient-public interrelationships.
Aesthetic Plastic Surgery is covered in Current Contents/Clinical Medicine, SciSearch, Research Alert, Index Medicus-Medline, and Excerpta Medica/Embase.